{
    "2018-04-10": [
        [
            {
                "time": "2018-04-05",
                "original_text": "FDA Approves First Contact Lens With Light-adaptive Technology",
                "features": {
                    "keywords": [
                        "FDA",
                        "approves",
                        "contact lens",
                        "light-adaptive technology"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Why J&J’s Fallen Stock Is Still Too Pricey",
                "features": {
                    "keywords": [
                        "J&J",
                        "fallen stock",
                        "pricey"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "DGRO, JNJ, AAPL, MSFT: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "DGRO",
                        "JNJ",
                        "AAPL",
                        "MSFT",
                        "ETF inflow"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Google to power Georgia data center with solar energy",
                "features": {
                    "keywords": [
                        "Google",
                        "Georgia",
                        "data center",
                        "solar energy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "renewable energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "How Merck & Co. Stock Performed in 1Q18",
                "features": {
                    "keywords": [
                        "Merck",
                        "stock performance",
                        "1Q18"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Analyst Recommendations for Teva Pharmaceutical in April 2018",
                "features": {
                    "keywords": [
                        "analyst recommendations",
                        "Teva Pharmaceutical",
                        "April 2018"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Analyst Recommendations for Valeant Pharmaceuticals in April",
                "features": {
                    "keywords": [
                        "analyst recommendations",
                        "Valeant Pharmaceuticals",
                        "April"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Novartis and Other Drug Stocks With FDA Catalysts in April",
                "features": {
                    "keywords": [
                        "Novartis",
                        "drug stocks",
                        "FDA catalysts",
                        "April"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Wired News – Johnson & Johnson to Pay Compensatory Damages over Claims Linking Cancer to Asbestos in Talc",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "compensatory damages",
                        "cancer",
                        "asbestos",
                        "talc"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}